株探米国株
英語
エドガーで原本を確認する
6-K 1 ysg-6k4q_-2025.htm 6-K 6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of March 2026

 

 

 

Commission File Number: 001-39703

 

 

 

Yatsen Holding Limited

 

Floor 39, Poly Development Plaza, No.832 Yue Jiang Zhong Road

Haizhu District, Guangzhou 510335

People’s Republic of China

 

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F  Form 40-F  Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 


EXHIBIT INDEX

 

Exhibit No.

 

Description

99.1

 

Press Release – Yatsen Announces Fourth Quarter and Full Year 2025 Financial Results

 

 


 

SIGNATURE

 

 

YATSEN HOLDING LIMITED

 

 

 

 

 

 

By:

 

/s/ Donghao Yang

Name:

 

Donghao Yang

Title:

 

Chief Financial Officer

 

Date: March 2, 2026


EX-99.1 2 ysg-ex99_1.htm EX-99.1 EX-99.1

 

Exhibit 99.1

Yatsen Announces Fourth Quarter and Full Year 2025 Financial Results

 

Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on March 2, 2026

 

GUANGZHOU, China, March 2, 2026 – Yatsen Holding Limited (“Yatsen” or the “Company”) (NYSE: YSG), a leading China-based beauty group, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025.

 

Fourth Quarter and Full Year 2025 Highlights

 

Total net revenues for the fourth quarter of 2025 increased by 20.1% to RMB1.38 billion (US$197.3 million) from RMB1.15 billion for the prior year period. Total net revenues for the full year of 2025 increased by 26.7% to RMB4.30 billion (US$614.6 million) from RMB3.39 billion for the prior year period.

 

Total net revenues from Skincare Brands1 for the fourth quarter increased by 51.9% to RMB842.8 million (US$120.5 million) from RMB554.8 million for the prior year period. As a percentage of total net revenues, total net revenues from Skincare Brands for the fourth quarter of 2025 were 61.1%, as compared with 48.3% for the prior year period. Total net revenues from Skincare Brands for the full year of 2025 increased by 63.5% to RMB2.28 billion (US$325.7 million) from RMB1.39 billion for the prior year period. As a percentage of total net revenues, total net revenues from Skincare Brands for the full year of 2025 were 53.0%, as compared with 41.1% for the prior year period.

 

Gross margin for the fourth quarter of 2025 was 77.7%, remaining largely flat as compared with 77.8% for the prior year period. Gross margin for the full year of 2025 increased to 78.2% from 77.1% for the prior year period.
Net income for the fourth quarter of 2025 was RMB3.0 million (US$0.4 million), as compared with a net loss of RMB378.8 million for the prior year period. Net loss for the full year of 2025 decreased by 87.0% to RMB92.4 million (US$13.2 million) from RMB710.2 million for the prior year period. Non-GAAP net income2 for the fourth quarter of 2025 was RMB41.2 million (US$5.9 million), as compared with RMB107.0 million for the prior year period. Non-GAAP net income for the full year of 2025 was RMB8.4 million (US$1.2 million), as compared with non-GAAP net loss of RMB128.2 million for the prior year period.

 

1 Include net revenues from Galénic, DR.WU (its mainland China business), Eve Lom and other skincare brands of the Company.

2 Non-GAAP net income (loss) is a non-GAAP financial measure. Non-GAAP net income (loss) is defined as net income (loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments and (vi) tax effects on non-GAAP adjustments.

 

Mr. Jinfeng Huang, Founder, Chairman and Chief Executive Officer of Yatsen, stated, “We are pleased to conclude 2025 with solid performances, demonstrating the long-term value of our strategic transformation. Throughout the year, we remained steadfast in our commitment to three core initiatives: driving R&D-led product innovation, strengthening brand equity across our multi-brand portfolio, and improving our overall profitability. As we enter 2026, we remain confident that these foundational strengths will drive sustainable growth and create lasting value for our shareholders.”

 


 

 

Mr. Donghao Yang, Director and Chief Financial Officer of Yatsen, commented, “Our recent financial results mark a pivotal milestone in our journey toward sustainable growth. For the fourth quarter, we are proud to have achieved net income and non-GAAP net income, alongside total net revenue growth. For the full year of 2025, we achieved year-over-year revenue growth, substantially narrowed our net loss, and achieved a non-GAAP net income turnaround. This success underscores the robust health of our brand portfolio as well as our improved operational efficiency. Looking ahead, we will continue to prioritize financial stability and strategic resource allocation to ensure Yatsen is well-positioned for long-term success.”

 

Fourth Quarter 2025 Financial Results

 

Net Revenues

 

Total net revenues for the fourth quarter of 2025 increased by 20.1% to RMB1.38 billion (US$197.3 million) from RMB1.15 billion for the prior year period. The increase was primarily due to a 51.9% year-over-year increase in net revenues from Skincare Brands, partially offset by a 9.1% year-over-year decrease in net revenues from Color Cosmetics Brands.3

 

3 Include Perfect Diary, Little Ondine, Pink Bear and other color cosmetics brands of the Company.

 

Gross Profit and Gross Margin

 

Gross profit for the fourth quarter of 2025 increased by 20.0% to RMB1.07 billion (US$153.2 million) from RMB893.0 million for the prior year period. Gross margin for the fourth quarter of 2025 was 77.7%, remaining largely flat as compared with 77.8% for the prior year period.

 

Operating Expenses

 

Total operating expenses for the fourth quarter of 2025 decreased by 15.6% to RMB1.08 billion (US$155.0 million) from RMB1.28 billion for the prior year period. As a percentage of total net revenues, total operating expenses for the fourth quarter of 2025 were 78.6%, as compared with 111.8% for the prior year period.

 

Fulfillment Expenses. Fulfillment expenses for the fourth quarter of 2025 were RMB77.0 million (US$11.0 million), as compared with RMB63.5 million for the prior year period. As a percentage of total net revenues, fulfillment expenses for the fourth quarter of 2025 were 5.6% as compared with 5.5% for the prior year period, remaining largely flat.

 

Selling and Marketing Expenses. Selling and marketing expenses for the fourth quarter of 2025 were RMB893.8 million (US$127.8 million), as compared with RMB690.6 million for the prior year period. As a percentage of total net revenues, selling and marketing expenses for the fourth quarter of 2025 increased to 64.8% from 60.1% for the prior year period. The increase was primarily driven by higher traffic acquisition costs amid intensified competition during the Double 11 shopping festival.
General and Administrative Expenses. General and administrative expenses for the fourth quarter of 2025 were RMB74.4 million (US$10.6 million), as compared with RMB100.1 million for the prior year period.

 


 

As a percentage of total net revenues, general and administrative expenses for the fourth quarter of 2025 decreased to 5.4% from 8.7% for the prior year period. The decrease was primarily driven by lower payroll expenses and share-based compensation expenses, coupled with the leveraging effect of higher total net revenues in the fourth quarter of 2025.

 

Research and Development Expenses. Research and development expenses for the fourth quarter of 2025 were RMB38.8 million (US$5.5 million), as compared with RMB26.3 million for the prior year period. As a percentage of total net revenues, research and development expenses for the fourth quarter of 2025 increased to 2.8% from 2.3% for the prior year period. The increase was primarily driven by higher payroll expenses resulting from a rise in research and development headcount.

 

Impairment of Goodwill. There was no impairment of goodwill for the fourth quarter of 2025, as compared with an impairment of goodwill of RMB403.1 million for the prior year period. Based on our assessment, no impairment indicators were identified as of December 31, 2025.

 

Loss / Income from Operations

 

Loss from operations for the fourth quarter of 2025 was RMB12.7 million (US$1.8 million), as compared with RMB390.7 million for the prior year period. Operating loss margin was 0.9%, as compared with 34.0% for the prior year period.

Non-GAAP income from operations4 for the fourth quarter of 2025 was RMB11.8 million (US$1.7 million), as compared with RMB93.2 million for the prior year period. Non-GAAP operating income margin5 was 0.9%, as compared with 8.1% for the prior year period.

Net Loss / Income

Net income for the fourth quarter of 2025 was RMB3.0 million (US$0.4 million), as compared with net loss of RMB378.8 million for the prior year period. Net income margin was 0.2%, as compared with net loss margin of 33.0% for the prior year period. Net income attributable to Yatsen’s ordinary shareholders per diluted ADS6 for the fourth quarter of 2025 was RMB0.08 (US$0.01), as compared with net loss attributable to Yatsen’s ordinary shareholders per diluted ADS of RMB3.98 for the prior year period.

 

Non-GAAP net income for the fourth quarter of 2025 was RMB41.2 million (US$5.9 million), as compared with RMB107.0 million for the prior year period. Non-GAAP net income margin was 3.0%, as compared with 9.3% for the prior year period. Non-GAAP net income attributable to Yatsen’s ordinary shareholders per diluted ADS7 for the fourth quarter of 2025 was RMB0.46 (US$0.07), as compared with RMB0.99 for the prior year period.

 

4 Non-GAAP income (loss) from operations is a non-GAAP financial measure. Non-GAAP income (loss) from operations is defined as income (loss) from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill.

5 Non-GAAP operating income (loss) margin is a non-GAAP financial measure, which is defined as non-GAAP net loss from operations as a percentage of total net revenues.

6 ADS refers to American depositary shares, each of which represents twenty Class A ordinary shares.

 


 

7 Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is a non-GAAP financial measure. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is defined as non-GAAP net income (loss) attributable to ordinary shareholders divided by the weighted average number of diluted ADS outstanding for computing diluted earnings per ADS. Non-GAAP net income (loss) attributable to ordinary shareholders is defined as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments, (vi) tax effects on non-GAAP adjustments and (vii) accretion to redeemable non-controlling interests.

 

Full Year 2025 Financial Results

 

Total net revenues for the full year of 2025 increased by 26.7% to RMB4.30 billion (US$614.6 million) from RMB3.39 billion for the prior year period, primarily attributable to a 63.5% year-over-year increase in net revenues from Skincare Brands, combined with a 1.9% year-over-year increase in net revenues from Color Cosmetics Brands.

 

Gross profit for the full year of 2025 increased by 28.4% to RMB3.36 billion (US$480.7 million) from RMB2.62 billion for the prior year period. Gross margin for the full year of 2025 increased to 78.2% from 77.1% for the prior year period. The increase was primarily attributable to increasing sales of higher-gross margin products.

 

Loss from operations for the full year of 2025 was RMB185.8 million (US$26.6 million), as compared with RMB824.9 million for the prior year period. Operating loss margin decreased to 4.3% from 24.3% for the prior year period, primarily because there was no impairment of goodwill for the full year of 2025.

 

Non-GAAP loss from operations for the full year of 2025 was RMB84.0 million (US$12.0 million), as compared with RMB224.3 million for the prior year period. Non-GAAP operating loss margin decreased to 2.0% from 6.6% for the prior year period.

 

Net loss for the full year of 2025 was RMB92.4 million (US$13.2 million), as compared with RMB710.2 million for the prior year period. Net loss margin decreased to 2.2% from 20.9% for the prior year period. Net loss attributable to Yatsen’s ordinary shareholders per diluted ADS for the full year of 2025 was RMB0.87 (US$0.12), as compared with RMB6.99 for the prior year period.

 

Non-GAAP net income for the full year of 2025 was RMB8.4 million (US$1.2 million), as compared with non-GAAP net loss of RMB128.2 million for the prior year period. Non-GAAP net income margin was 0.2%, as compared with non-GAAP net loss margin of 3.8% for the prior year period. Non-GAAP net income attributable to Yatsen’s ordinary shareholders per diluted ADS for the full year of 2025 was RMB0.19 (US$0.03), as compared with non-GAAP net loss attributable to Yatsen’s ordinary shareholders per diluted ADS of RMB1.26 for the prior year period.

 

Balance Sheet and Cash Flow

 

As of December 31, 2025, the Company had cash, restricted cash and short-term investments of RMB1.05 billion (US$150.7 million), as compared with RMB1.36 billion as of December 31, 2024.

 

Net cash used in operating activities for the fourth quarter of 2025 was RMB69.4 million (US$9.9 million), as compared with net cash generated from operating activities of RMB202.2 million for the prior year period. Net cash used in operating activities for the full year of 2025 was RMB94.7 million (US$13.5 million), as compared with RMB243.7 million for the prior year period.

 


 

 

 

Business Outlook

 

For the first quarter of 2026, the Company expects its total net revenues to be between RMB958.6 million and RMB1.08 billion, representing a year-over-year increase of approximately 15% to 30%. These forecasts reflect the Company’s current and preliminary views on the market and operational conditions, which are subject to change.

 

Exchange Rate

 

This announcement contains translations of certain Renminbi (“RMB”) amounts into U.S. dollars (“US$”) at specified rates solely for the convenience of the reader. Unless otherwise noted, all translations from RMB to US$ were made at a rate of RMB6.9931 to US$1.00, the exchange rate in effect as of December 31, 2025, as set forth in the H.10 statistical release of The Board of Governors of the Federal Reserve System. The Company makes no representation that any RMB or US$ amounts could have been, or could be, converted into US$ or RMB, as the case may be, at any particular rate, or at all.

 

Conference Call Information

 

The Company’s management will hold a conference call on Monday, March 2, 2026, at 7:30 A.M. U.S. Eastern Time or 8:30 P.M. Beijing Time to discuss its financial results and operating performance for the fourth quarter and full year 2025.

 

United States (toll free):

+1-888-346-8982

International:

+1-412-902-4272

Mainland China (toll free):

400-120-1203

Hong Kong, SAR (toll free):

800-905-945

Hong Kong, SAR:

+852-3018-4992

 

 

The replay will be accessible through Monday, March 9, by dialing the following numbers:

 

United States:

+1-855-669-9658

International:

+1-412-317-0088

Replay Access Code:

2950633

 

A live and archived webcast of the conference call will also be available on the Company’s investor relations website at http://ir.yatsenglobal.com/.

 

 


 

About Yatsen Holding Limited

 

Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the mission of creating an exciting new journey of beauty discovery for consumers around the world. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear,Galénic, DR.WU (its mainland China business) and Eve Lom. The Company’s flagship brand, Perfect Diary, is one of the leading color cosmetics brands in China in terms of retail sales value. The Company primarily reaches and engages with customers directly both online and offline, with expansive presence across all major e-commerce, social and content platforms in China.

 

For more information, please visit http://ir.yatsenglobal.com/.

 

Use of Non-GAAP Financial Measures

 

The Company uses non-GAAP income (loss) from operations, non-GAAP operating income (loss) margin, non-GAAP net income (loss), non-GAAP net income (loss) margin, non-GAAP net income (loss) attributable to ordinary shareholders and non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS, each a non-GAAP financial measure, in reviewing and assessing its operating performance. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with U.S. GAAP. The Company presents these non-GAAP financial measures because they are used by the management to evaluate operating performance and formulate business plans. Non-GAAP financial measures help identify underlying trends in its business, provide further information about its results of operations, and enhance the overall understanding of its past performance and future prospects. The Company defines non-GAAP income (loss) from operations as income (loss) from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill. Non-GAAP operating income (loss) margin is non-GAAP income (loss) from operations as a percentage of total net revenues. The Company defines non-GAAP net income (loss) as net income (loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments and (vi) tax effects on non-GAAP adjustments. Non-GAAP net income (loss) margin is non-GAAP net income (loss) as a percentage of total net revenues. The Company defines non-GAAP net income (loss) attributable to ordinary shareholders as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments, (vi) tax effects on non-GAAP adjustments and (vii) accretion to redeemable non-controlling interests. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is computed using non-GAAP net income (loss) attributable to ordinary shareholders divided by weighted average number of diluted ADS outstanding for computing diluted earnings per ADS.

 

However, the non-GAAP financial measures have limitations as analytical tools as the non-GAAP financial measures are not presented in accordance with U.S. GAAP and may differ from the non-GAAP information used by other companies, including peer companies, and therefore their comparability may be limited. The Company compensates for these limitations by reconciling the non-GAAP financial measures to the nearest U.S. GAAP performance measure, all of which should be considered when evaluating performance. The Company encourages investors and others to review its financial information in its entirety and not rely on a single financial measure.

 


 

Reconciliations of Yatsen’s non-GAAP financial measures to the most comparable U.S. GAAP measure are included at the end of this press release.

 

Safe Harbor Statement

 

This announcement contains statements that may constitute “forward-looking” statements which are made pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to,” and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the Securities and Exchange Commission (“SEC”), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about the Company’s beliefs, plans, outlook and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company’s growth strategies; its future business development, results of operations and financial condition; its ability to continue to roll out popular products and maintain popularity of existing products; its ability to anticipate and respond to changes in industry trends and consumer preferences and behavior in a timely manner; its ability to attract and retain new customers and to increase revenues generated from repeat customers; its expectations regarding demand for and market acceptance of its products and services; its ability to integrate newly-acquired businesses and brands; trends and competition in and relevant government policies and regulations relating to China’s beauty market; changes in its revenues and certain cost or expense items; and general economic conditions globally and in China. Further information regarding these and other risks is included in the Company’s filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

 

For investor and media inquiries, please contact:

 

Yatsen Holding Limited

Investor Relations

E-mail: ir@yatsenglobal.com

 

 


 

YATSEN HOLDING LIMITED

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(All amounts in thousands, except for share, per share data or otherwise noted)

 

 

December 31,

 

 

December 31,

 

 

December 31,

 

 

 

2024

 

 

2025

 

 

2025

 

 

 

RMB'000

 

 

RMB'000

 

 

USD'000

 

Assets

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

817,395

 

 

 

765,379

 

 

 

109,448

 

Restricted cash

 

 

-

 

 

 

42,117

 

 

 

6,023

 

Short-term investments

 

 

539,130

 

 

 

246,008

 

 

 

35,179

 

Accounts receivable, net

 

 

214,558

 

 

 

220,870

 

 

 

31,584

 

Inventories, net

 

 

386,054

 

 

 

508,730

 

 

 

72,747

 

Prepayments and other current assets

 

 

381,404

 

 

 

450,970

 

 

 

64,488

 

Amounts due from related parties

 

 

9,113

 

 

 

114

 

 

 

16

 

Total current assets

 

 

2,347,654

 

 

 

2,234,188

 

 

 

319,485

 

Non-current assets

 

 

 

 

 

 

 

 

 

Investments

 

 

664,579

 

 

 

653,560

 

 

 

93,458

 

Property and equipment, net

 

 

74,373

 

 

 

77,014

 

 

 

11,013

 

Goodwill, net

 

 

155,029

 

 

 

155,029

 

 

 

22,169

 

Intangible assets, net

 

 

559,708

 

 

 

537,509

 

 

 

76,863

 

Deferred tax assets

 

 

1,381

 

 

 

1,435

 

 

 

205

 

Right-of-use assets, net

 

 

147,501

 

 

 

173,915

 

 

 

24,870

 

Other non-current assets

 

 

20,642

 

 

 

14,332

 

 

 

2,049

 

Total non-current assets

 

 

1,623,213

 

 

 

1,612,794

 

 

 

230,627

 

Total assets

 

 

3,970,867

 

 

 

3,846,982

 

 

 

550,112

 

Liabilities, redeemable non-controlling interests and shareholders' equity

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

 

Accounts and notes payable

 

 

72,090

 

 

 

149,371

 

 

 

21,360

 

Advances from customers

 

 

19,574

 

 

 

28,821

 

 

 

4,121

 

Accrued expenses and other liabilities

 

 

460,143

 

 

 

348,700

 

 

 

49,863

 

Amounts due to related parties

 

 

28,884

 

 

 

21,262

 

 

 

3,040

 

Income tax payables

 

 

20,088

 

 

 

13,690

 

 

 

1,958

 

Lease liabilities due within one year

 

 

39,409

 

 

 

53,435

 

 

 

7,641

 

Total current liabilities

 

 

640,188

 

 

 

615,279

 

 

 

87,983

 

Non-current liabilities

 

 

 

 

 

 

 

 

 

Deferred tax liabilities

 

 

103,306

 

 

 

107,906

 

 

 

15,430

 

Deferred income-non current

 

 

14,832

 

 

 

-

 

 

 

-

 

Lease liabilities

 

 

109,526

 

 

 

123,157

 

 

 

17,611

 

Total non-current liabilities

 

 

227,664

 

 

 

231,063

 

 

 

33,041

 

Total liabilities

 

 

867,852

 

 

 

846,342

 

 

 

121,024

 

Redeemable non-controlling interests

 

 

50,984

 

 

 

1,337

 

 

 

191

 

Shareholders' equity

 

 

 

 

 

 

 

 

 

Ordinary Shares (US$0.00001 par value; 10,000,000,000 ordinary shares authorized, comprising of 6,000,000,000 Class A ordinary shares, 960,852,606 Class B ordinary shares and 3,039,147,394 shares each of such classes to be designated as of December 31, 2024 and December 31, 2025; 2,096,600,883 Class A shares and 600,572,880 Class B ordinary shares issued as of December 31, 2024 and December 31, 2025; 1,234,627,468 Class A ordinary shares and 600,572,880 Class B ordinary shares outstanding as of December 31, 2024, 1,276,663,163 Class A ordinary shares and 600,572,880 Class B ordinary shares outstanding as of December 31, 2025)

 

 

173

 

 

 

173

 

 

 

25

 

Treasury shares

 

 

(1,276,330

)

 

 

(1,250,678

)

 

 

(178,845

)

Additional paid-in capital

 

 

12,273,767

 

 

 

12,296,367

 

 

 

1,758,357

 

Statutory reserve

 

 

28,147

 

 

 

31,527

 

 

 

4,508

 

Accumulated deficit

 

 

(8,057,297

)

 

 

(8,141,545

)

 

 

(1,164,225

)

Accumulated other comprehensive income

 

 

86,866

 

 

 

74,760

 

 

 

10,693

 

Total Yatsen Holding Limited shareholders' equity

 

 

3,055,326

 

 

 

3,010,604

 

 

 

430,513

 

Non-controlling interests

 

 

(3,295

)

 

 

(11,301

)

 

 

(1,616

)

Total shareholders' equity

 

 

3,052,031

 

 

 

2,999,303

 

 

 

428,897

 

Total liabilities, redeemable non-controlling interests and shareholders' equity

 

 

3,970,867

 

 

 

3,846,982

 

 

 

550,112

 

 

 


 

YATSEN HOLDING LIMITED

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(All amounts in thousands, except for share, per share data or otherwise noted)

 

 

For the Three Months Ended December 31,

 

 

For the Year Ended December 31,

 

 

 

2024

 

 

2025

 

 

2025

 

 

2024

 

 

2025

 

 

2025

 

 

 

RMB'000

 

 

RMB'000

 

 

USD'000

 

 

RMB'000

 

 

RMB'000

 

 

USD'000

 

Total net revenues

 

 

1,148,522

 

 

 

1,379,443

 

 

 

197,258

 

 

 

3,393,414

 

 

 

4,298,124

 

 

 

614,624

 

Total cost of revenues

 

 

(255,536

)

 

 

(308,105

)

 

 

(44,058

)

 

 

(776,236

)

 

 

(936,780

)

 

 

(133,958

)

Gross profit

 

 

892,986

 

 

 

1,071,338

 

 

 

153,200

 

 

 

2,617,178

 

 

 

3,361,344

 

 

 

480,666

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fulfilment expenses

 

 

(63,517

)

 

 

(77,025

)

 

 

(11,014

)

 

 

(216,540

)

 

 

(253,926

)

 

 

(36,311

)

Selling and marketing expenses

 

 

(690,584

)

 

 

(893,771

)

 

 

(127,808

)

 

 

(2,268,793

)

 

 

(2,852,288

)

 

 

(407,872

)

General and administrative expenses

 

 

(100,122

)

 

 

(74,443

)

 

 

(10,645

)

 

 

(444,373

)

 

 

(303,628

)

 

 

(43,418

)

Research and development expenses

 

 

(26,345

)

 

 

(38,788

)

 

 

(5,547

)

 

 

(109,287

)

 

 

(137,296

)

 

 

(19,633

)

Impairment of goodwill

 

 

(403,076

)

 

 

-

 

 

 

-

 

 

 

(403,076

)

 

 

-

 

 

 

-

 

Total operating expenses

 

 

(1,283,644

)

 

 

(1,084,027

)

 

 

(155,014

)

 

 

(3,442,069

)

 

 

(3,547,138

)

 

 

(507,234

)

Loss from operations

 

 

(390,658

)

 

 

(12,689

)

 

 

(1,814

)

 

 

(824,891

)

 

 

(185,794

)

 

 

(26,568

)

Financial income

 

 

20,973

 

 

 

6,947

 

 

 

993

 

 

 

86,136

 

 

 

40,721

 

 

 

5,823

 

Foreign currency exchange (loss) gain

 

 

(22,129

)

 

 

1,176

 

 

 

168

 

 

 

(20,399

)

 

 

13,374

 

 

 

1,912

 

(Loss) income from equity method investments, net

 

 

(8,104

)

 

 

2,304

 

 

 

329

 

 

 

1,386

 

 

 

5,940

 

 

 

849

 

Impairment of investments

 

 

-

 

 

 

(13,453

)

 

 

(1,924

)

 

 

-

 

 

 

(13,453

)

 

 

(1,924

)

Other income, net

 

 

18,726

 

 

 

20,150

 

 

 

2,881

 

 

 

44,461

 

 

 

46,690

 

 

 

6,677

 

(Loss) income before income tax expenses

 

 

(381,192

)

 

 

4,435

 

 

 

633

 

 

 

(713,307

)

 

 

(92,522

)

 

 

(13,231

)

Income tax benefits (expenses)

 

 

2,388

 

 

 

(1,398

)

 

 

(200

)

 

 

3,086

 

 

 

108

 

 

 

15

 

Net (loss) income

 

 

(378,804

)

 

 

3,037

 

 

 

433

 

 

 

(710,221

)

 

 

(92,414

)

 

 

(13,216

)

Net loss (income) attributable to non-controlling interests and redeemable non-controlling interests

 

 

(5,430

)

 

 

5,028

 

 

 

719

 

 

 

2,047

 

 

 

11,546

 

 

 

1,651

 

Net (loss) income attributable to Yatsen's shareholders

 

 

(384,234

)

 

 

8,065

 

 

 

1,152

 

 

 

(708,174

)

 

 

(80,868

)

 

 

(11,565

)

Shares used in calculating loss per share (1):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of Class A and Class B ordinary shares:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    Basic

 

 

1,930,413,426

 

 

 

1,879,474,484

 

 

 

1,879,474,484

 

 

 

2,025,072,131

 

 

 

1,862,554,166

 

 

 

1,862,554,166

 

    Diluted

 

 

1,930,413,426

 

 

 

2,018,668,765

 

 

 

2,018,668,765

 

 

 

2,025,072,131

 

 

 

1,862,554,166

 

 

 

1,862,554,166

 

Net (loss) income per Class A and Class B ordinary share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    Basic

 

 

(0.20

)

 

 

0.00

 

 

 

0.00

 

 

 

(0.35

)

 

 

(0.04

)

 

 

(0.01

)

    Diluted

 

 

(0.20

)

 

 

0.00

 

 

 

0.00

 

 

 

(0.35

)

 

 

(0.04

)

 

 

(0.01

)

Net (loss) income per ADS (20 ordinary shares equal to 1 ADS)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    Basic

 

 

(3.98

)

 

 

0.09

 

 

 

0.01

 

 

 

(6.99

)

 

 

(0.87

)

 

 

(0.12

)

    Diluted

 

 

(3.98

)

 

 

0.08

 

 

 

0.01

 

 

 

(6.99

)

 

 

(0.87

)

 

 

(0.12

)

* In the fourth quarter of 2025, we made certain out of period adjustments mainly relating to revenues and cost of revenues to correct certain prior periods errors mainly occurred during the sales return and inventory receipt processes, which reduced quarterly profit by RMB14.6 million. Out of the RMB14.6 million adjustments, RMB7.4 million adjustments were related to prior years. Based on our quantitative and qualitative analysis, we do not believe these errors are material to our financial position or results of operations for the current year and for any prior years or prior quarters individually or in aggregate.

 

 


 

 

 

For the Three Months Ended December 31,

 

 

For the Year Ended December 31,

 

 

 

2024

 

 

2025

 

 

2025

 

 

2024

 

 

2025

 

 

2025

 

Share-based compensation expenses are included in the operating expenses as follows:

 

RMB'000

 

 

RMB'000

 

 

USD'000

 

 

RMB'000

 

 

RMB'000

 

 

USD'000

 

Fulfilment expenses

 

 

237

 

 

 

2

 

 

0

 

 

 

387

 

 

 

213

 

 

 

30

 

Selling and marketing expenses (income)

 

 

2,259

 

 

 

1,411

 

 

 

202

 

 

 

(42

)

 

 

4,959

 

 

 

709

 

General and administrative expenses

 

 

17,443

 

 

 

10,940

 

 

 

1,564

 

 

 

89,941

 

 

 

48,646

 

 

 

6,956

 

Research and development expenses

 

 

356

 

 

 

1,636

 

 

 

234

 

 

 

888

 

 

 

5,213

 

 

 

745

 

Total

 

 

20,295

 

 

 

13,989

 

 

 

2,000

 

 

 

91,174

 

 

 

59,031

 

 

 

8,440

 

(1) Authorized share capital is re-classified and re-designated into Class A ordinary shares and Class B ordinary shares, with each Class A ordinary share being entitled to one vote and each Class B ordinary share being entitled to twenty votes on all matters that are subject to shareholder vote.

 

 


 

YATSEN HOLDING LIMITED

UNAUDITED RECONCILIATIONS OF GAAP AND NON-GAAP RESULTS

(All amounts in thousands, except for share, per share data or otherwise noted)

 

 

 

For the Three Months Ended December 31,

 

 

For the Year Ended December 31,

 

 

 

2024

 

 

2025

 

 

2025

 

 

2024

 

 

2025

 

 

2025

 

 

 

RMB'000

 

 

RMB'000

 

 

USD'000

 

 

RMB'000

 

 

RMB'000

 

 

USD'000

 

Loss from operations

 

 

(390,658

)

 

 

(12,689

)

 

 

(1,814

)

 

 

(824,891

)

 

 

(185,794

)

 

 

(26,568

)

Share-based compensation expenses

 

 

20,295

 

 

 

13,989

 

 

 

2,000

 

 

 

91,174

 

 

 

59,031

 

 

 

8,440

 

Impairment of goodwill

 

 

403,076

 

 

 

-

 

 

 

-

 

 

 

403,076

 

 

 

-

 

 

 

-

 

Amortization of intangible assets resulting from assets and business acquisitions

 

 

60,447

 

 

 

10,502

 

 

 

1,502

 

 

 

106,385

 

 

 

42,729

 

 

 

6,110

 

Non-GAAP income (loss) from operations

 

 

93,160

 

 

 

11,802

 

 

 

1,688

 

 

 

(224,256

)

 

 

(84,034

)

 

 

(12,018

)

Net (loss) income

 

 

(378,804

)

 

 

3,037

 

 

 

433

 

 

 

(710,221

)

 

 

(92,414

)

 

 

(13,216

)

Share-based compensation expenses

 

 

20,295

 

 

 

13,989

 

 

 

2,000

 

 

 

91,174

 

 

 

59,031

 

 

 

8,440

 

Impairment of goodwill

 

 

403,076

 

 

 

-

 

 

 

-

 

 

 

403,076

 

 

 

-

 

 

 

-

 

Impairment of investments

 

 

-

 

 

 

13,453

 

 

 

1,924

 

 

 

-

 

 

 

13,453

 

 

 

1,924

 

Amortization of intangible assets resulting from assets and business acquisitions

 

 

60,447

 

 

 

10,502

 

 

 

1,502

 

 

 

106,385

 

 

 

42,729

 

 

 

6,110

 

Revaluation of investments on the share of equity method investments

 

 

7,386

 

 

 

(3,475

)

 

 

(497

)

 

 

(10,019

)

 

 

(15,839

)

 

 

(2,265

)

Tax effects on non-GAAP adjustments

 

 

(5,421

)

 

 

3,725

 

 

 

533

 

 

 

(8,644

)

 

 

1,435

 

 

 

205

 

Non-GAAP net income (loss)

 

 

106,979

 

 

 

41,231

 

 

 

5,895

 

 

 

(128,249

)

 

 

8,395

 

 

 

1,198

 

Net (loss) income attributable to Yatsen's shareholders

 

 

(384,234

)

 

 

8,065

 

 

 

1,152

 

 

 

(708,174

)

 

 

(80,868

)

 

 

(11,565

)

Share-based compensation expenses

 

 

20,295

 

 

 

13,989

 

 

 

2,000

 

 

 

91,174

 

 

 

59,031

 

 

 

8,440

 

Impairment of goodwill

 

 

403,076

 

 

 

-

 

 

 

-

 

 

 

403,076

 

 

 

-

 

 

 

-

 

Impairment of investments

 

 

-

 

 

 

13,453

 

 

 

1,924

 

 

 

-

 

 

 

13,453

 

 

 

1,924

 

Amortization of intangible assets resulting from assets and business acquisitions

 

 

60,079

 

 

 

10,228

 

 

 

1,463

 

 

 

104,853

 

 

 

41,390

 

 

 

5,919

 

Revaluation of investments on the share of equity method investments

 

 

7,386

 

 

 

(3,475

)

 

 

(497

)

 

 

(10,019

)

 

 

(15,839

)

 

 

(2,265

)

Tax effects on non-GAAP adjustments

 

 

(5,393

)

 

 

3,724

 

 

 

533

 

 

 

(8,533

)

 

 

1,490

 

 

 

213

 

Non-GAAP net income (loss) attributable to Yatsen's shareholders

 

 

101,209

 

 

 

45,984

 

 

 

6,575

 

 

 

(127,623

)

 

 

18,657

 

 

 

2,666

 

Shares used in calculating loss per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of Class A and Class B ordinary shares:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    Basic

 

 

1,930,413,426

 

 

 

1,879,474,484

 

 

 

1,879,474,484

 

 

 

2,025,072,131

 

 

 

1,862,554,166

 

 

 

1,862,554,166

 

    Diluted

 

 

2,049,750,667

 

 

 

2,018,668,765

 

 

 

2,018,668,765

 

 

 

2,025,072,131

 

 

 

2,009,621,005

 

 

 

2,009,621,005

 

Non-GAAP net income (loss) attributable to ordinary shareholders per Class A and Class B ordinary share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    Basic

 

 

0.05

 

 

 

0.02

 

 

 

0.00

 

 

 

(0.06

)

 

 

0.01

 

 

 

0.00

 

    Diluted

 

 

0.05

 

 

 

0.02

 

 

 

0.00

 

 

 

(0.06

)

 

 

0.01

 

 

 

0.00

 

Non-GAAP net income (loss) attributable to ordinary shareholders per ADS (20 ordinary shares equal to 1 ADS)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    Basic

 

 

1.05

 

 

 

0.49

 

 

 

0.07

 

 

 

(1.26

)

 

 

0.20

 

 

 

0.03

 

    Diluted

 

 

0.99

 

 

 

0.46

 

 

 

0.07

 

 

 

(1.26

)

 

 

0.19

 

 

 

0.03